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Summary 
Several  cytokines,  especially  granulocyte/macrophage colony-stimulating factor  (GM-CSF) 
and tumor necrosis factor ot (TNF-o0, have been identified that foster the development of den- 
dritic  cells from blood and bone marrow precursors in suspension cultures.  These precursors 
are reported to be infrequent or to yield small numbers of dendritic cells in colony-forming as- 
says. Here we readily identify dendritic cell colony-forming units (CFU-DC) that give rise to 
pure dendritic cell colonies. Human CD34  + bone marrow progenitors were expanded in semi- 
solid cultures with serum-replete medium containing c-kit-hgand,  GM-CSF, and TNF-0t. The 
addition of TNF-ct to GM-CSF did not alter the number of typical GM colonies but did gen- 
erate pure dendritic cell colonies that accounted for N40% of the total colony growth. When 
the two distinct types of colonies were plucked from methylcellulose and tested for T  cell- 
stimulatory activity in the mixed leukocyte reaction, the potency of colony-derived dendritic 
cells exceeded that of CFU-GM progeny from the same cultures by at least 1.5-2 logs.  Immu- 
nophenotyping and cytochemical staining of the CFU-DC-derived progeny was also charac- 
teristic  of dendritic cells. Other myeloid cells were not identified in these colonies. The addi- 
tion  of c-kit-ligand  to  GM-CSF- and  TNF-ot--supplemented suspensions  of CD34  §  bone 
marrow cells expanded CFU-DCs almost 100-fold by 14 d. We conclude that normal human 
CD34  + bone marrow cells include substantial  numbers ofclonogenic progenitors, distinct from 
CFU-GMs,  that  can  give rise  to  pure  dendritic  cell  colonies.  These  CFU-DCs can be  ex- 
panded for several weeks by in vitro culture with c-kit-ligand, and their differentiation requires 
exogenous TNF-0t in addition to GM-CSF. We speculate that this  dendritic cell-committed 
pathway may in the steady state  contribute cells to the  epidermis and afferent lymph, where 
dendritic cells are the principal myeloid cell type, and may increase the numbers of these spe- 
cialized  antigen-presenting cells during T  cell-mediated immune responses. 
C 
Ytokines  hke  GM-CSF  and  TNF-ot  are  known  to 
support the development of dendritic cells from pro- 
genitors in blood and marrow (1-8). We have found that 
the addition of c-kit-hgand (KL) 1 substantially  increases  the 
Portions of this work were presented in abstract form at the Keystone 
Symposium,  Dendritic Cells: Antigen-presenting Cells of T and B Lym- 
phocytes, in Taos, NM, 10-16 March 1995. 
~  Abbreviations used in this paper. BMMNC, bone marrow mononuclear 
cells; CFU-DC, dendritic cell CFU; CFU-GM, granulocyte/macrophage 
CFU; epo, erythropoietin; KL, c-kit-hgand. 
yield of dendritic cells in suspension cultures relative  to the 
starting  number  of human  CD34  +  bone  marrow  cells. 
Nevertheless,  these  myeloid  progeny are  heterogeneous, 
dendritic  cells constitute  only ,"~10-15%  of the  total,  and 
monocytes constitute the remaining class II MHC positive 
cells  (8). The monocyte progeny are  plastic  adherent,  are 
CD14  +, and are weak stimulators of the MLtL, whereas the 
mature dendritic cells are nonadherent, are CD14-, and are 
potent MLtk stimulators.  In prior reports of colony-form- 
ing assays, dendritic cells have represented a minor fraction 
of the clonogenic progeny as well.  Inaba et at. identified a 
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that yielded mixed myeloid colonies after exposure to GM- 
CSF  (5),  including 0.5-1.5%  highly stimulatory dendritic 
cells. Reid and  colleagues first reported the existence of a 
GM-CSF/IL-3 and  TNF-~x  responsive progenitor among 
human CD34 + cells that could yield colonial progeny with 
some of the features of dendritic cells (2).  These  CD34 +- 
derived colonies were mixed, however, and included addi- 
tional cells with macrophage characteristics. Dendritic cells 
are not as easily distinguished from monocytes/macrophages 
in the human as they are in the mouse, and it has been dif- 
ficult to generate human dendritic cell colonies of sufficient 
frequency and purity to  confirm the  functional as well as 
phenotypic and/or morphologic identity of these progeny 
as true dendritic cells. 
We  therefore  undertook  colony-forming  assays  using 
human  CD34 +  bone  marrow  cells and  various  combina- 
tions ofKL, GM-CSF, and TNF-R in serum-replete, semi- 
solid  media.  Morphologically distinct  colony  types  were 
identified, plucked, and compared cytochemically, pheno- 
typically, and  functionally. Recruitment  and  expansion of 
CFUs and the contribution of KL were determined in sec- 
ondary clonogenic assays after serial expansions in bulk sus- 
pension  culture.  This approach has  identified a  novel he- 
matopoietic pathway for the  clonogenic differentiation of 
pure  dendritic cells from  dendritic  cell CFUs  (CFU-DC) 
that are roughly comparable in frequency with, but distinct 
from,  granulocyte/macrophage  CFUs  (CFU-GM)  among 
human CD34 § bone marrow progenitors. 
Materials and Methods 
Culture Media and Cytokines.  CD34 + bone marrow progeni- 
tors were cultured in IMDM (GIBCO BRL, Gaithersburg, MD) 
with  50  I-tg/ml  gentamicin  (Sigma  Chenfical  Co.,  St.  Louis, 
MO),  7.3  X  10 -s M  monothioglycerol (Sigma Chemical Co.), 
20%  FCS  (heat inactivation not required;  Gemini Bioproducts, 
Calabasas,  CA), and exogenous cytokines as indicated. MLR as- 
says for  evaluating mature,  differentiated progeny  used  RPMI 
1640  (GIBCO BRL) with 10 mM Hepes (Sigma Chemical Co.), 
1 mM glutamine (GIBCO BRL), 5  X  10 -5 M  2-ME (Eastman 
Kodak Co., Rochester,  NY), penicillin (100  U/ml)-streptomy- 
cin (100  ~g/ml)  (GIBCO BRL), and 10% heat-inactivated nor- 
mal human serum. The recombinant human cytokines used were 
as follows: 20 ng/ml KL, or stem cell factor (Amgen Biologicals, 
Thousand Oaks, CA); 100 ng/ml GM-CSF (Sandoz Pharmaceu- 
ticals  Corp., East Hanover,  NJ);  10 ng/rnl TNF-~  (Genentech, 
Inc., San Francisco, CA); 50 ng/ml IL-3 (Amgen Biologicals); 20 
ng/n-Ll IL-6 mutein (mutant of recombinant native protein; hn- 
clone  Systems,  Inc.,  New  York);  and  5  U/ml  erythropoietin 
(epo; Amgen Biologicals). 
Isolation of Human GD34 + Bone Marrow Progenitors.  Small ali- 
qnots of bone marrow were obtained from normal donors already 
undergoing harvesting for allogeneic transplantation. CD34 + cells 
were isolated by positive selection of anti-CD34  (clone 11.1.6, 
IgG1; Oncogene Science Inc., Uniondale, NY)-opsonized bone 
marrow mononuclear cells (BMMNC),  using sheep anti-mouse 
IgG1  (Fc-specific) immunomagnetic beads  (Dynal,  Oslo,  Nor- 
way) (8, 9). After 16-20 h of incubation at 37~  in IMDM-20% 
FCS, the beads detached and CD34 + cells were harvested. The 
yield was ,-'1% of the starting BMMNC, and further selection of 
more primitive progenitors was not undertaken. CD34 + progen- 
itors isolated from either unmodified or partially T cell-depleted, 
soybean agglutinin-negative (10,  11)  bone marrow gave similar 
results. 
Culture  of Human  CD34 + Progenitors in Suspension  and  Colony- 
forming Assays.  Colony-forming assays were performed in tripli- 
cate starting with 1-2 X  103 CD34 + cells in 1-ml cultures. Semi- 
solid medium  consisted of either  0.36%  agarose  (FMC  Corp. 
Bioproducts, Rockland, ME) and complete IMDM-20% FCS, or 
1.2%  methylcellulose (FMC  Corp.  Bioproducts)  and  complete 
IMDM-30%  FCS with additional supplements of 5  ￿  10 -5  M 
2-ME, 2  ￿  10 -3 M  glutamine, and 2.5-5  ￿  10 -6 M  hemin. Ex- 
ogenous cytokine supplements have been indicated for each ex- 
periment.  CFUs  were  quantified by  counting colonies of/>50 
cells after 12-14 d of culture. Baseline CFUs were enumerated in 
primary colony cultures established at the time of CD34 + pro- 
genitor isolation. Recruitment and expansion of CFUs were as- 
sessed  in  secondary clonogenic assays after serial expansions  in 
suspension culture. Suspension cultures of CD34 + bone marrow 
cells were initiated with complete IMDM-20% FCS at an initial 
density of 2  ￿  105/5  ml in 35-mm tissue  culture wells. All cul- 
tures were mgintained at 37~  in humidified 5% CO2. 
Cytochemical and Immunophenotypic  Staining  of Cytospin  Prepara- 
tions.  Individual colonies  of a  single  morphologic  type  were 
plucked from methylcellulose after 12-14 d of culture under di- 
rect inspection by inverse-phase microscopy in a laminar air flow 
hood. The cells were resuspended in IMDM-20% FCS without 
cytokines and washed.  Cells were resuspended in  RPMI  1640- 
10% normal human serum and warmed in a 37~  water bath, af- 
ter which 0.5-1  X  104  ceUs/100  I.~1 were cytocentrifuged onto 
glass slides (900 rpm for 3 min; Cytospin 2; Shandon Inc., Pitts- 
burgh, PA), air dried, and acetone fixed. Morphology was assessed 
by  Wright-Giemsa  staining.  Cytochemical  evaluation included 
staining for  nonspecific  esterase  (c~-naphthyl  butyrate  esterase) 
(12), specific esterase (chloroacetate esterase; Sigma Chemical Co.), 
myeloperoxidase (Sigma Chemical  Co.),  and  acid  phosphatase 
(Sigma Chemical Co.). Colonies were also stained cytochemicatly 
in situ after methanol dehydration and acetone fixation ofagarose 
plates.  Immunophenotyping used mAbs to HLA-DR/DQ (9.3C9 
subclone of9.3F10, IgG2~; HB  180),  CDla (OKT6, IgG]; CRL 
8020),  and  CD14  (3C10,  IgG2b; TIB  228)  (all from  American 
Type Culture Collection, Rockville, MD). These were followed 
by biotinylated goat anti-mouse Ig (No. 4753, Tago, Inc., Burl- 
ingame,  CA)  and  a  preformed  avidin-biotinylated horseradish 
peroxidase complex (Vectastain  Elite ABC Kit; Vector Laborato- 
ries,  Inc., Burlingame, CA). Positive staining was detected using 
diaminobenzidine tetrahydrochloride  (Polysciences,  Inc.,  War- 
ring'ton, PA) as the chromogenic enzyme substrate. 
PBMC and Enrichment of Blood Dendritic Cells, Monocytes, and T 
Lymphocytes(13-16).  Mononuclear  leukocyte  subpopulations 
were prepared according to previously published procedures, us- 
ing  Ficoll-Hypaque-separated PBMC  from  normal  leukocyte 
concentrates (Greater NY Blood Center, New York). Primary T 
cells were rosetted with neuraminidase-treated sheep erythrocytes 
followed by  elution  over  nylon  wool  columns.  Mature  blood 
dendritic cells  were  purified from  the nonadherent,  T  cell-de- 
pleted, sheep erythrocyte rosette-negative fraction after 36 b  of 
culture, using adherence to human lg-coated plates for depIetion 
of contaminant  monocytes  and  13.75  g/100  ml  metrizamide 
(Metrizamide AG; GIBCO BRL) for final enrichment in a low- 
density interface. 
1112  Dendritic Cell Colonies from Human CD34 + Bone Marrow Progenitors Allogeneic MLR.  The allogeneic MLP, was used as a test for 
accessory function of marrow-derived APCs, compared with the 
stimulatory  activity  of  a  representative  population  of  mature 
blood dendritic cells in the same assay. It was not logistically  pos- 
sible  to  obtain  blood  dendritic  cells  and  CD34  +  bone  marrow 
progenitors from the same donors, but the T  cell responders were 
always  from the  same donor  in  a  given experiment.  Candidate 
APCs  were  washed free of cytokines and irradiated  with  1,500 
rad  137Cs (sufficient  to prevent continued  background prolifera- 
tion  of CD34 §  progeny) before addition  in graded doses  to re- 
sponder T cells in 96-microwell tissue culture plates  (1.5  ￿  10  s T 
cells/flat-bottomed  microwell  or  1  ￿  105  T  cells/round-bot- 
tomed microwell). Accessory activity of a particular APC popula- 
tion was based on [3H]thymidine incorporation (1  p~Ci [3H]TdP,/ 
microwell;  New  England  Nuclear,  Boston,  MA)  by  the  re- 
sponder T cells during an 8-12-h pulse on d 4-5 of the allogeneic 
MLR. Responses have been expressed as the mean cpm +  SD of 
triplicates.  T  cells or APCs only (1,500  rad t37Cs) always incorpo- 
rated <200-300  cpm. 
Results 
The Addition  of TNF-c~ to  GMoCSF Generates Pure Den- 
dritic Cell Colonies, in Addition  to  Typical CFU-GM-derived 
Colonies.  Human CD34 + bone marrow progenitors were 
cultured  in  methylcellulose  supplemented  with  KL  and 
GM-CSF, with or without exogenous TNF-0~ (1, 2, 8). By 
direct  inspection  under  phase-contrast  microscopy,  typical 
myeloid  GM  colonies  developed  irrespective  of the  addi- 
tion of TNF-c~  (Fig.  1 A). When TNF-oL was added to the 
combination  of KL and  GM-CSF,  a  morphologically  dis- 
tinct type of colony developed in addition  to GM colonies 
(Fig.  1,  B and  C).  These novel colonies were more loosely 
aggregated  when  compared  with  the  compact  GM  colo- 
nies.  An  individual  candidate  dendritic  cell  colony  was 
comprised  of cells with  very elongated,  spiny  cytoplasmic 
processes that were plastic adherent at the undersurface  (ar- 
rowheads), with  overlying  clusters  of cells,  many  of which 
extended  veiled cytoplasmic processes into  different planes 
of the medium (arrows). KL increased  the number and size 
of all colonies but did not alter their gross morphology. 
To  characterize  the  cell  progeny,  individual  colonies 
were harvested,  pooled,  and resuspended  as described  after 
12-14  d  of primary culture  in methylcellulose.  Figs.  2  and 
3 illustrate cytocentrifuged preparations from the two types 
of  colonies.  Nonspecific  esterase  (e~-naphthyl  butyrate)- 
positive cells were identified in both types of colonies grown 
in  KL,  GM-CSF,  and  TNF-o~.  Cells with  a  strongly posi- 
tive, pancellular stain for nonspecific esterase (Fig. 2, A  and 
B, solid arrowheads) constituted  10.8%  of the  cells from the 
GM  colonies  and  8.6%  of the cells from the putative  den- 
dritic  cell  colonies  (500  cell  differentials).  The  candidate 
dendritic  cell  colonies  also included  ~10%  (49  out  of 500 
cells  counted)  cells with  a  dense  perinuclear  positivity  for 
nonspecific  esterase  (Fig.  2  B, short arrows) and  many cells 
with a faint perinuclear blush  (Fig.  2  B, long thin arrows). In 
contrast,  myeloperoxidase  was  limited  exclusively  to  cells 
in  the  GM  colonies  (Fig.  2  C,  compare  with  Fig.  2  D). 
Acid phosphatase was densely positive in some cells in the 
GM colonies (Fig. 2 E, arrowheads), whereas a minor popula- 
tion of cells stained with a blushlike pattern in the candidate 
dendritic cell colonies (Fig. 2 F, short arrows). Wright-Giemsa 
staining  (not  shown)  revealed  predominantly  eosinophils 
among the granulocytes in the GM colonies,  admixed with 
monocyte/macrophages,  the former reflective of the effect 
of KL. As expected from prior reports investigating the ef- 
fects  of TNF-cx  on  granulopoiesis  (17,  18),  neutrophilic 
granulocyte  differentiation  in  GM  colonies  was  also  sup- 
pressed  by  TNF-cx.  The  candidate  dendritic  cell  colonies 
were devoid of granulocytes and included  exclusively large 
cells with  cytoplasmic projections,  perinuclear  clear zones, 
and  folded/lobulated  nuclei,  all of which  are characteristic 
of blood dendritic  cells. 
Immunophenotyping  is  illustrated  in  Fig.  3.  All  of the 
cells from the candidate dendritic  cell colonies were intensely 
positive  for  HLA-DR./DQ  and  exhibited  the  prominent 
cytoplasmic veils  (Fig.  3 A, arrows) that typify mature  den- 
dritic cells. The CFU-GM-derived progeny included some- 
what less strongly positive cells for class II MHC  that lacked 
cytoplasmic projections (Fig. 3  B), although even a rare pos- 
itive  cell  with  the  veiled  dendritic  morphology  illustrated 
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Figure  1.  CD34 §  bone  marrow progeni- 
tors cultured in methylceLlulose/IMDM-30% 
FCS, KL, GM-CSF, and TNF-a yield novel 
dendritic cell colonies, in  addition to  typical 
GM myeloid colonies. CD34 + bone marrow 
progenitors cultured for 12-14 d with 20 ng/ 
ml KL,  100  ng/ml GM-CSF,  and  10  ng/ml 
TNF-a,  in  1.2%  methylcellulose/IMDM- 
30%  FCS,  developed into  two  morphologi- 
cally distinct types of  colonies: (A) typical GM 
colonies  (X65);  and  (B  and  C)  separate but 
more loosely aggregated dendritic cell colo- 
nies comprised of plastic  adherent cells (arrow- 
heads) with elongated, spiny cytoplasmic pro- 
cesses at the undersurface, and overlying cells 
(arrows  highlight a  few  of these)  extending 
veils into different planes of the medium (B, 
X130, and C, )<65, photographed at different 
planes in the methylcellulose culture). Figure 2.  Cytochemical staining of the clonogenic progeny of CFU-GM and CFU-DC. CD34  + bone marrow progenitors cultured for 12-14 d with 
20 ng/ml KL, 100 ng/ml GM-CSF, and 10 ng/ml TNF-0e in 1.2% methylcellulose/IMDM-30%  FCS, developed into the two distinct types of colonies 
depicted in Fig. 1. These were plucked under direct microscopic inspection, pooled, and resuspended into single-ceU  suspensions. CFU-GM progeny are 
depicted in A,  C, and E; CFU-DC progeny are shown in B, D, and F.  (A and B) 0l-napthyl butyrate esterase (￿  (C and D) myeloperoxidase 
(X250); (E and F) acid phosphatase (￿  See text for arrow descriptors. In situ staining of colonies in agarose plates confirmed these cytochemical pro- 
files (not shown). 
in Fig. 3  A  could be identified (~<1% of the total cells; not 
shown  in  Fig.  3  B).  CDla +  cells  were  also  identified  in 
both  types  of colonies  (Fig.  3,  C  and  D),  although  they 
constituted a very small fraction of the cells in the GM col- 
onies (Fig.  3  D;  the field shown is not typical but was  se- 
lected  to  illustrate  the  presence  of positive  cells).  CD14 
completely  segregated  the  two  kinds  of  colonies.  True 
CD14 + cells were limited exclusively to the CFU-GM-de- 
rived progeny (Fig. 3  F) and were comparable in frequency 
to  the  percentage  of nonspecific  esterase-positive  cells  in 
these  GM  colonies  (Fig.  2  A).  More  than  98-99%  of the 
cells  in the  candidate  dendritic  cell  colonies  were  clearly 
CD14-  with  a  rare  cell  (~<1-2%)  staining very  fain@  at 
most  (Fig. 3  E).  CD14  aim cells were  not found in the GM 
colonies. 
CFU-GMs and CFU-DCs Represent Distinct Clonogenic Pro- 
genitors.  CD34 § bone marrow cells were cultured in 0.36% 
agarose/IMDM-20%  FCS,  supplemented with the  exoge- 
1114  Dendritic Cell Colonies from Human CD34 + Bone Marrow Progenitors Figure 3.  Immunophenotype of  the clonogenic progeny of  CFU-GM and CFU-DC. CD34 + bone marrow progenitors cultured for 12-14 d with 20 
ng/ml KL, 100 ng/ml GM-CSF, and 10 ng/ml TNF-et in 1.2% methylcelluose/IMDM-30% FCS, developed into the two distinct types of  colonies de- 
picted in Fig. 1. These were plucked under direct microscopic inspection, pooled, and resuspended into single-cell suspensions. A, C, and E are CFU- 
DC-derived progeny, and B, D, and F  are CFU-GM-derived progeny. (A and B) HLA-DR/DQ  staining by 9.3C9,  with arrows highlighting the 
unique, very fine cytoplasmic processes of dendritic cells (these may be more easily visualized on the printed page using hand-held magnification); (C and 
D) CDla staining by OKT6;  (E and F) CD14 staining by 3C10, with a typical monocyte in the GM colonies indicated by an arrow in F  (the punctate 
staining in the other small cells is background staining of eosinophil granules). ￿  165. 
Table  1.  Primary  Cloning Efficiency of CD34  + Human Bone Marrow Cells 
GM colonies*  Dendritic cell colonies* 
Percent  Percent  Percentage 
Condition  Cytokine stimuli  Number of  Absolute  cloning  Absolute  cloning  of total 
number  *  experiments  yield  efficiency  yield  efficiency  colonies 
1  None  4  29  _•  29  0.03  1  •  l  0.001  3.3 
2  20 ng KL +  50 ng IL-3  + 
20 ng IL-6  •  5  U  epo  6  7,880  _  1,754  7.9  3  •  3  0.003  0.03 
3  I0 ng TNF-et  3  5  •  5  0.005  0  _  0  0  0 
4  100 ng GM-CSF  6  1,667  +  239  1.7  16  •  7  0.016  0.96 
5  100 ng GM-CSF  6  1,576  •  500  1.6  1,176  •  165  1.2  42.7 
6  20 ng KL •  100 ng GM-CSF  + 
10 ng TNF-ed  7  2,852  •  970  2.9  2,031  •  224  2  41.6 
* Cytokine doses are per milliliter. 
*Colony counts are adjusted to l0  s CD34 + bone marrow progenitors cultured at 1-2 ￿  103/ml in 0.36% agarose/IMDM-20% FCS for 12-14 d; the 
yields represent means --- SEM of triplicate plates per condition per experiment. 
~A dose response evaluation of TNF-0t added to 20 ng/ml KL and 100 ng/ml GM-CSF demonstrated an increasing yield of dendritic cell colonies 
with increasing amounts ofTNF-ot. KL, GM-CSF +  1 ng/ml TNF-et: 150 --+ 30 DC colonies; +  2.5 ng/ml TNF-et: 450  •  100 DC colonies; +  5 
ng/ml TNF-~: 850 •  50 DC colonies; +  I0.0 ng/ml TNF-et: 4,300  +  400 DC colonies (triplicate means +  SEM, n  =  1 experiment). 
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Figure  4.  CD34 + bone marrow progenitors,  grown in colony assays 
under serum-replete conditions with KL, GM-CSF, and TNF-~t, gener- 
ate potent immunostimulatory progeny in dendritic cell colonies but not 
in colonies derived from typical myeloid CFU-GM. CD34 + bone mar- 
row progenitors were cultured for 12-14 d with 20 ng/ml KL, 100 ng/ml 
GM-CSF, with or without 10 ng/ml TNF-cl, in 1.2% methylcellulose/ 
IMDM-30%  FCS.  Colonies were plucked under direct microscopic in- 
spection, pooled,  and resuspended into single-cell suspensions. Stimula- 
tory  capacity  was  assessed in  primary  allogeneic  MLRs  and  compared 
with that effected by blood dendritic cells as a positive control. All stimu- 
lator  populations  were  exposed to  1,500  rad  137Cs and  then added  in 
graded doses to  10  s allogeneic T  cells  in U-bottomed microwells. Cells 
were pulsed with 1 I~Ci/well [3H]TdR from 92 to 104 h. Circles denote 
dendritic cell colonies; squares denote  GM colonies grown in the pres- 
ence ofKL, GM-CSF, and TNF-et; triangles denote GM colonies grown 
in  KL  and  GM-CSF  only;  and  diamonds  denote  blood  dendritic  cell 
comparison. Results are representative of three experiments. Please note 
log scale. 
nous cytokines shown in Table 1, and scored after 12-14 d. 
Based on six  experiments performed in triplicate,  CD34 + 
bone marrow progenitors yielded similar numbers of GM 
colonies  in  the  presence  of GM-CSF,  with  or  without 
TNF-0t. With the addition of TNF-o~, dendritic cell colo- 
nies developed in addition to GM colonies.  This effect of 
TNF-ot was dose related but plateaued between 10 and 100 
ng/ml (not shown).  KL affected the primary cloning effi- 
ciency of all  CD34 + progenitors by doubhng the number 
and increasing the size of both types of colonies. 
Dendritic Cell Colonies Are Comprised of Potent Immunostim- 
ulatory Cells  for the Initiation of Primary Allogeneic Responses by 
Resting T Cells.  After the two colony types were harvested 
from methylcellulose, single-cell suspensions were tested as 
stimulators of resting allogeneic T  cells. As shown in Fig. 4, 
the  capacity of cells  derived from the  candidate  dendritic 
cell  colonies to stimulate an aUogeneic MLR was identical 
to that of mature blood dendritic cells. This confirmed the 
substantial  expansion and enrichment  of dendritic  cells  in 
these  unique  colonies.  Cells from GM colonies generated 
in  the  presence  of KL,  GM-CSF,  and  TNF-ot  exerted 
weak  but  measurable  stimulatory  activity,  in  accordance 
with  the  ~1%  candidate  dendritic  cells  seen  by  class  II 
MHC staining of these colonies. Their stimulatory capacity 
was nevertheless ,-1.5 logs less potent than the cells  from 
dendritic cell colonies, and cells from GM colonies grown 
in the absence of TNF-0~ were >2 logs less potent. 
KL Synergizes with  GM-CSF and  TNF-(r  to Recruit and 
Expand the Pool of Clonogenic Progenitors (CFUs) Responsive to 
GM-CSF and  TNF-e~-induced  Dendritic Cell Expansion  and 
Differentiation.  To quantify expansion of committed pro- 
genitors,  CD34 + bone marrow cells were cultured in sus- 
pension in IMDM-20% FCS with the cytokine combina- 
tions  shown  in  Fig.  5.  At  7-d intervals,  these  suspension 
cultures were harvested, washed, and either (A) replated in 
liquid suspension at the initial starting concentration  (4  ￿ 
104 cells/ml) with the same cytokines for an additional 7 d 
of cell expansion, or plated in 0.36% agarose/IMDM-20% 
FCS for 12-14  d with  (B) a positive control combination 
of KL, IL-3, IL-6, and epo to quantify expansion of CFU- 
GM and  erythroid burst-forming unit,  or with  (C)  GM- 
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Figure 5.  Progenitor expansion and replating ef- 
ficiency of human CD34  + bone marrow cells:  ef- 
fect of KL.  CD34  +  bone  marrow  cells were  cul- 
tured  in  IMDM-20%  FCS  suspension  cultures 
supplemented with the following cytokines: no ex- 
ogenous cytokine (circles); KL, IL-3, IL-6, and epo 
(squares); GM-CSF and TNF-0t (triangles); and KL, 
GM-CSF,  and TNF-cr  (diamonds).  Cytokine doses 
were  as  follows:  20  ng/ml KL,  100  ng/ml  GM- 
CSF,  10 ng/ml TNF-(x, 50 ng/ml IL-3, 20 ng/ml 
IL-6,  and 5  U/nil epo.  (A)  Weekly expansion of 
total  cell  numbers in  suspension culture  with  the 
respective cytokine conditions, adjusted to a start- 
ing cell dose of 4  ￿  104 per condition.  (B and C) 
Cells expanded in suspension culture with exoge- 
nous cytokines (shown in A) were harvested at weekly intervals. One cohort was returned to suspension culture for continued expansion. Another cohort 
of cells was cultured in IMDM-20% FCS-0.36% agarose, (B) supplemented with KL, IL-3, IL-6, and epo to determine the numbers of CFU-GM + 
erythroid burst-forming units that had been expanded in suspension based on colony growth in semisolid medium; or (C) supplemented with GM-CSF 
and TNF-0t to quantify expansion of CFU-DC based on subsequent dendritic cell colony growth in semisolid medium. Colonies were enumerated 12- 
14 d after secondary replating. Baseline or "input" CFUs were determined by colony growth from day 0 in the respective cytokines. CFU yields have 
been adjusted to a starting cell dose of 4  ￿  104 CD34  + bone marrow progenitors per condition. Means are derived from pooled data from three experi- 
ments, with each condition performed in triplicate. Error bars represent the SEM. Similar results were obtained in three additional experiments. Please 
note log scale. Also note that all symbols refer to primary suspension culture conditions in A. 
1116  Dendritic Cell Colonies from Human CD34 + Bone Marrow Progenitors KL expanded the pool of committed clonogenic progen- 
itors responsive to  GM-CSF-  and TNF-ot-induced den- 
dritic cell differentiation by almost 100-fold during the first 
and second weeks of suspension culture. This was  deter- 
mined by dividing the  number of dendritic  cell colonies 
generated in agarose after weekly expansion in suspension 
culture  with  KL,  GM-CSF,  and TNF-0t by the  baseline 
number of dendritic cell colonies generated by GM-CSF 
and TNF-ot from day 0 ofCD34 + isolation. Even with pri- 
mary exposure to a  non-dendritic  cell-selective cytokine 
combination,  like  KL,  IL-3,  IL-6,  and  epo,  progenitors 
with the capacity to generate dendritic cells when second- 
arily exposed to GM-CSF and TNF-ot expanded almost 30- 
fold over baseline. For purposes of comparison, KL, IL-3, 
IL-6, and epo expanded CFU-GM N80-fold by day 21; and 
KL, GM-CSF, and TNF-ot expanded CFU-GM '~40-fold 
by days  14 and 21. Progenitors responsive to GM or den- 
dritic cell colony-differentiating cytokines were maintained 
for several weeks in suspension culture by KL, although ab- 
solute CFU numbers declined after 14-21 d. In the absence 
of KL, the number of progenitors increased minimally dur- 
ing the first week of suspension culture but declined to al- 
most undetectable levels thereafter. 
Discussion 
Using a  combination of morphologic, phenotypic, and 
functional criteria, we have identified a novel hematopoie- 
tic pathway for the generation of pure dendritic cell colo- 
nies.  These  dendritic  cell  colonies  develop  from normal 
human CD34 § bone marrow progenitors under serum-re- 
plete conditions supplemented by GM-CSF  and TNF-0t. 
Dendritic cell colonies are distinct from and develop in ad- 
dition to typical myeloid GM  colonies under these same 
cytokine conditions. GM-CSF, in the absence of TNF-a, 
does not support growth  of dendritic cell colonies. As  is 
true  of other  hematopoietic  progenitor populations,  KL 
enhances by approximately twofold the primary cloning ef- 
ficiency of dendritic cell progenitors. KL also  expands the 
pool of committed clonogenic precursors for dendritic cell 
colonies  by  almost  100-fold  during  the  first  and  second 
weeks of culture. 
These  pure  human  dendritic  cell  colonies  differ from 
previously  described  myeloid  colonies  containing  small 
numbers of dendritic cells (2, 5,  19).  Inaba et al. generated 
mixed myeloid colonies from class II MHC negative mu- 
rine bone marrow precursors in the presence of GM-CSF 
and 10% FCS (5). These colonies included 0.5-1.5% den- 
dritic cells, indicating that murine phagocytes (granulocytes 
and macrophages) share a common MHC class II negative 
precursor with dendritic cells at some point in their devel- 
opment. Reid et al. reported a clonable dendritic cell pro- 
genitor in both human marrow and blood (19).  They fur- 
ther demonstrated that this precursor was enriched among 
the CD34 + population and dependent upon GM-CSF and 
TNF-~x (2). However, the resultant colonies had relatively 
few dendritic cells (4-50 dendritic cells per colony) and in- 
cluded additional cells with macrophage morphology. When 
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they cultured a heterogeneous population of nonadherent 
BMMNC in methylcellulose with GM-CSF, IL-3, with or 
without  G-CSF,  and  TNF-ot  or TNF-[3,  rare  candidate 
colonies of pure dendritic  cells  were described (2).  Den- 
dritic  cell colonies were identified solely by morphology 
and  CDla  expression,  however,  and  their  cloning  effi- 
ciency was <0.05% from this undefined progenitor popu- 
lation  (2).  Limited  cell  yields  did  not  permit  additional 
phenotypic characterization or functional comparisons with 
known dendritic cells to assess stimulatory activity. 
It  should  be  noted  that  CDla  is  not  unique  to  thy- 
mocytes and  Langerhans/dendritic  cells,  however,  as  cy- 
tokines like GM-CSF  and IL-4 can induce  expression of 
CD1  epitopes on monocytes (20, 21).  Our own data cor- 
roborate this finding, based on the occasional CDla  + cells 
noted in the GM colonies. Other single criteria could be 
equally misleading, e.g., nonspecific esterase,  which is not 
only  present  in  mature  monocytes  but  also  in  resident 
Langerhans cells, in which it diminishes with maturation in 
culture  (22).  CD14  and myeloperoxidase definitively dis- 
criminated the two types of colonies, with positives found 
only in the  GM  colonies. Cells in  12-14-d dendritic cell 
colonies were clearly CD14 and myeloperoxidase negative. 
A  rare cell that stained very faintly with anti-CD14 could 
be identified in dendritic cell, but not GM, colonies; this is 
consistent with prior reports of freshly isolated blood, resi- 
dent  epidermal,  or  cytokine-generated  marrow-derived 
dendritic cells (8, 23-25). The combination of these mor- 
phologic  and  phenotypic  criteria  therefore  distinguished 
two types of colonies, each of which developed alongside 
the other from normal CD34 §  progenitors when TNF-ot 
was added to GM-CSF with or without KL under serum- 
replete conditions. 
These clonogenic progeny also exhibited divergent prop- 
erties for the stimulation of resting primary T  cells. We used 
the  allogeneic mixed leukocyte reaction for this purpose, 
because it highlights the  specialized accessory function of 
mature dendritic cells vs other APCs for the initiation of T 
cell-mediated immune responses (for review see reference 
26). The stimulatory capacity of dendritic cell progeny gen- 
erated  in  colonies with  KL,  GM-CSF,  and  TNF-a  was 
equivalent to that of mature blood dendritic cells and ex- 
ceeded that of GM colony-derived cells by at least 1.5-2 
logs.  Interestingly, the GM colonies that arose in the pres- 
ence of TNF-oc exerted low but measurable stimulatory ac- 
tivity that was greater than that effected by GM  colonies 
grown in the absence of TNF-a. Even a trace growth of 
dendritic cells among the human GM progeny generated in 
the presence of GM-CSF and TNF-ot, vs GM-CSF alone, 
could account for this level of stimulation. This would be 
in accordance with the murine system (5) and is supported 
by  our  observation  of ~<1% candidate  dendritic  cells  by 
Wright-Giemsa and class II MHC staining of these particu- 
lar GM colonies. The alternative possibility of contamina- 
tion with cells from adjacent dendritic cell colonies during 
manual harvesting cannot be excluded. 
Substantial expansion by KL was demonstrated for both 
GM and dendritic cell progenitors in secondary colony as- says  performed  weekly  after  expansion  in  IMDM-20% 
FCS  and  cytokines.  Bone  marrow  CD34 +  dendritic  cell 
progenitors expanded almost  100-fold during the first and 
second weeks of primary suspension  culture in KL,  GM- 
CSF,  and  TNF-a.  Even  KL with  IL-3,  IL-6, and  epo  in 
primary suspension cultures effected a 25-fold expansion of 
GM-CSF/TNF-cx-responsive dendritic cell progenitors in 
secondary clonogenic assays. These degrees of progenitor ex- 
pansion are in marked contrast to that supported by GM-CSF 
and TNF-e~ in the absence of KL.  Furthermore,  although 
absolute colony numbers  declined after 2  wk,  progenitors 
responsive to differentiating cytokines were maintained by 
KL for several weeks of in vitro culture. 
The development of dendritic cell colonies, without al- 
teration in the growth of CFU-GM,  indicates that CD34 + 
bone marrow cells include a dendritic cell progenitor that is 
distinct from  CFU-GM.  DC  colonies do  not  result from 
TNF  modification  of committed  CFU-GM,  as  the  latter 
remain constant in number  and appearance with or with- 
out TNF-cx. This CFU-DC  is KL responsive, increasing its 
cloning  efficiency and  expanding  almost  100-fold  during 
the first 2  wk of serial cultures.  Dendritic cell colonies of 
this  frequency  and  purity  have  not  been  previously  re- 
ported.  Mixed  myeloid  colonies  with  trace  numbers  of 
dendritic cells reflect the small proportion of dendritic cells 
in most tissues where they are identified in vivo (for review 
see reference 26). Epidermis and afferent lymph, however, 
contain  many  dendritic  cells but  few  if any  monocytes/ 
macrophages. The  CFU-DCs that we have described may 
constitute an  active hematopoietic pathway for generating 
dendritic cell populations in these sites in vivo under steady- 
state conditions. This pathway may have the additional role 
of increasing the numbers of these specialized APCs in re- 
sponse  to  inflammatory cytokines during T  cell-mediated 
immune responses. 
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